Takara Bio Inc. (4974) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Takara Bio Inc. (4974:JPX), powered by AI.

Current Price
¥1,144
P/E Ratio
132.1
Market Cap
137.7B
Sector
Healthcare
What is the Takara Bio Inc. stock price forecast?

Takara Bio Inc. is currently trading at ¥1,144. View real-time AI analysis on Alpha Lenz.

What is Takara Bio Inc. insider trading activity?

View the latest insider trading data for Takara Bio Inc. on Alpha Lenz.

What is Takara Bio Inc.'s P/E ratio?

Takara Bio Inc.'s P/E ratio is 132.1.

Takara Bio Inc.

JPX · 4974
¥1,144+1(+0.09%)Market closedJPX regular session 09:00–15:00 JST
Ask about Takara Bio Inc.'s future dividend policy...
Alpha Chat Insight

Takara Bio Inc. trades at a P/E of 132.1 (premium valuation) with modest ROE of 0.9%.

Ask for details

Company Overview

Takara Bio Inc. operates as a biotechnology company with a focus on developing innovative biotechnological solutions in various scientific fields. The company's primary function is to research, develop, and supply cutting-edge life science technologies, which include PCR reagents and instruments, gene therapy tools, and stem cell technologies. Takara Bio Inc. significantly impacts the life sciences industry, serving sectors such as pharmaceutical research, diagnostics, and academic institutions worldwide. Established in Japan, Takara Bio leverages its expertise to enhance biological research, therapeutic development, and personalized medicine. The company also explores possibilities in agricultural and industrial biotechnology. Within the financial markets, Takara Bio holds a notable position due to its commitment to advancing scientific discovery and therapeutic innovation. By providing essential tools and technologies, the company supports numerous breakthroughs in health care and life sciences, meeting the evolving needs of researchers and medical professionals globally.

CEOMr. Tsuyoshi Miyamura
SectorHealthcare
IndustryBiotechnology
Employees1,779

Company Statistics

FY 2025

Profile

¥137,676,763,224Market Cap
¥45,039,000,000Revenue
0.00Shares Out
1,779Employees

Margins

57.88%Gross
15.74%EBITDA
5.03%Operating
4.43%Pre-Tax
2.41%Net

Valuation

132.13P/E
1.19P/B
3.06EV/Sales
15.45EV/EBITDA
-31.05P/FCF

Growth (CAGR)

-12.70%Rev 3Yr
5.44%Rev 5Yr
-57.20%Op Inc 3Yr
-18.44%Op Inc 5Yr
-62.06%Net Inc 3Yr
-22.27%Net Inc 5Yr

Returns

0.88%ROA
0.92%ROE
1.64%ROIC

Financial Health

¥29,549,000,000Cash & Cash Equivalents
¥-20,061,000,000Net Debt
8.19%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Takara Bio Inc. (ticker: 4974) is a company listed on JPX in the Healthcare sector (Biotechnology). It has approximately 1,779 employees. Market cap is $137.7B.

The current price is 1,144 with a P/E ratio of 132.13x and P/B of 1.19x.

ROE is 0.92% and operating margin is 5.03%. Annual revenue is $45.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Takara Bio Inc. (4974) Stock Forecast 2026 ¥1,144 — Price, Financials & Analyst Targets | Alpha Lenz